Insurers Must Cover Updated Cervical Cancer Screenings Free
Published Date: 1/5/2026
Notice
Summary
Starting soon, many health plans must cover updated cervical cancer screening tests for women without charging extra. These changes affect group and individual insurance plans and aim to keep women healthier by catching cancer early. The new rules come after expert reviews and public feedback, so expect smoother, no-cost screenings that save lives and money.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
No-Copay Coverage Required for Updated Screenings
Non-grandfathered group health plans and health insurance issuers offering group or individual coverage must cover, without cost-sharing, the services and screenings listed in the updated Women's Preventive Services Guidelines. The HRSA Administrator accepted the update on December 29, 2025, and plans with plan or policy years that begin 1 year after that date (for most plans, in 2027) must provide the coverage.
At-Home HPV Self-Collection Covered Option
The updated Guideline states that patient-collected high-risk human papillomavirus (hrHPV) testing is an appropriate method and should be offered as an option for cervical cancer screening in women aged 30 to 65 years at average risk. For covered plans, this option falls under the HRSA-supported Guidelines and must be included without cost-sharing beginning for plan years that start 1 year after acceptance (accepted Dec 29, 2025).
Changed Screening Methods and Intervals
The Guideline updates screening method and timing: women aged 21–29 should have cervical cytology (Pap test) every 3 years; women aged 30–65 should be screened with primary hrHPV testing every 5 years (preferred) or cytology plus hrHPV co-testing every 5 years; if hrHPV testing is unavailable, continue cytology alone every 3 years. These recommendations apply to average-risk women and are part of the services that covered plans must include without cost-sharing beginning for plan or policy years starting 1 year after acceptance (accepted Dec 29, 2025).
Follow-Up and Additional Tests Covered
The updated Guideline adds that additional testing and pathologic evaluation (for example, cytology, biopsy, colposcopy, extended genotyping, dual stain) may be required to complete the screening process and are recommended to complete screening for malignancies. For non-grandfathered plans, these services are part of the Guideline-covered preventive services and must be covered without cost-sharing for plan or policy years beginning 1 year after acceptance (accepted Dec 29, 2025).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in